Epilepsy. Epilepsy
Conditions
Interventions
0.05-0.2 mg of clonidine will be administered to patients orally based on their weight (for 30 kg 0.15 to 0.2 mg of clonidine)..
Treatment - Drugs
0.05-0.2 mg of clonidine will be administered to patients orally based on their weight (for 30 kg 0.15 to 0.2 mg of clonidine).
Sponsors
Vice Chancellor for Research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 2 and 12 years old; history of epilepsy; history of failure to sedation with other routine medications than clonidine. Exclusion criteria: cardiovascular disease; gastrointestinal disease; pulmonary disease; renal disease; hemodynamic instability.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consciousness. Timepoint: Before intervention- continuously after intervention until complete consciousness. Method of measurement: Assessing by physician. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessing by physician.;Respiratory rate. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessing by physician.;Blood pressure. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessing by physician.;Body tempreture. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessed using thermometer.;Blood oxygen saturation. Timepoint: Before intervention- 2 hours after intervention. Method of measurement: Assessed using pulsoximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Masoumeh Ghasempour Alamdari
Clinical Educational Center of Children, Tabriz University of Medical Sciences
Outcome results
None listed